Bintai Kinden, IJN to collaborate on Covid-19 vaccine development

Bintai Kinden executive director Azri Azerai presenting a mock cheque to IJN director of clinical research Datuk Dr Suhaini Kadiman as the initial grant under the Bintai Healthcare-IJN Covid 19 Research Grant to fund the necessary research programmes.

KUALA LUMPUR: Bintai Kinden Corp Bhd has entered into a collaboration with Institut Jantung Negara Sdn Bhd (IJN) to develop a Covid-19 vaccine in Malaysia.

In a statement, the group said it had entered into a collaborative agreement with the national heart institute to establish a partnership in the commercial development of the Ii-Key-SARS-CoV-2 coronavirus (Covid-19) vaccine.